Opsonix

Opsonix

Developing a broad-spectrum pathogen-extracting therapy to transform the treatment of sepsis.

Launch date
Employees
Market cap
-
Enterprise valuation
€29—44m (Dealroom.co estimates Oct 2015.)
Cambridge Massachusetts (HQ)
Authorizing premium user...